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Introduction: We studied factors associated with the continuum of HIV care in Belgium.
Methods: Data of the national registration of new HIV diagnosis and of the national cohort of HIV-infected patients in care were
combined to obtain estimates of and factors related with proportions of HIV-infected patients in each step of the continuum of
care from diagnosis to suppressed viral load (VL). Factors associated with ignorance of HIV seropositivity were analyzed among
patients co-infected with HIV and STI in the Belgian STI sentinel surveillance network. Associated factors were identified by
multivariate logistic regression.
Results: Among 4038 individuals diagnosed with HIV between 2007 and 2010, 90.3% were linked to care. Of 11684 patients in
care in 2010, 90.8% were retained in care up to the following year, 88.3% of those were on ART, of whom 95.3% had suppressed
VL (B500 cp/ml) (Figure 1). In multivariate analyses, factors associated with ignoring HIV status were being younger
(pB0.001), being heterosexual compared to MSM, and of a region of origin other than Belgium, Sub-Saharan Africa and Europe.
Non-Belgian regions of origin were associated with lower entry and retention in care (pB0.001 for both). Preoperative HIV
testing was associated with lower entry in care (p0.003). MSM had a higher retention in care (pB0.001), whilst IDU had
lower retention (p0.004). Low CD4 at first clinical contact and clinical reasons for HIV testing were independently associated
with being on ART (pB0.001 for both); whilst prenatal HIV diagnosis was associated with lower proportion on ART (p0.016)
and lower proportion with suppressed VL among those on ART (p0.005). Older age was associated with both being on ART
and having suppressed VL among those on ART (p0.007 and pB0.001 respectively), independently of time since HIV
diagnosis (Table 1).
Conclusions: Regions of origin and risk groups (MSM/heterosexual/IDU) are the main factors associated with ignorance of HIV
seropositivity, entry and retention in care, but once the HIV patient is retained in care, no effect of these factors on the
proportions on ART and with suppressed VL are observed. The association of prenatal HIV diagnosis and proportions on ART and
with suppressed VL could be biased by transitory CD4 disturbances during pregnancy and ART discontinuation after pregnancy.
The higher probabilities of older patients to be on ART and have suppressed VL once retained in care could be influenced by
factors not studied here like comorbidities, adherence or duration on ART.
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Figure 1. The continuum of HIV care in Belgium.
Table 1. Adjusted OR for factors associated with each step of the continuum of HIV care
Risk factors
Adjusted OR (95% CI)a
Undiagnosed HIV
Adjusted OR (95% CI)a
No entry in care
Adjusted OR (95%
CI)a No retention
Adjusted OR (95%
CI)a On ART
Adjusted OR (95% CI)a
Suppressed VL (B500 cp/ml)
Sex
Male 1 1 1 1 1
Female 1.32 (0.394.44) 0.88 (0.581.34) 0.87 (0.701.07) 0.76 (0.551.04)b 1.02 (0.731.42)
Age at diagnosis
B40 yrs 1 1 1 1 1
]40 yrs 0.42 (0.270.64) 0.98 (0.691.39) 1.05 (0.861.28) 1.31 (1.041.65)b 1.75 (1.272.42)
Way of transmission
Heterosexual 1 1 1 1 1
MSM 0.39 (0.160.95) 0.86 (0.521.44) 0.61 (0.470.78) 0.80 (0.581.09)b 1.06 (0.721.56)
IDU / 1.50 (0.554.11) 1.88 (1.222.88) 2.42 (0.698.46)b 1.46 (0.524.11)
Region of origin
Belgium 1 1 1 1 1
Sub-Saharan Africa 1.02 (0.333.14) 3.11 (1.845.26) 1.41 (1.121.78) 0.90 (0.661.23)b 0.73 (0.511.03)b
Europe 0.83 (0.411.69) 2.74 (1.594.71) 1.86 (1.382.52) 0.97 (0.671.40)b 0.97 (0.571.66)b
Other 2.25 (1.264.04) 3.23 (1.795.83) 1.54 (1.102.17) 0.90 (0.591.37)b 0.89 (0.511.48)
Reason for testing
Patient’s request / 1 1 1 1
Clinical arguments / 0.98 (0.641.50) 0.95 (0.741.21) 1.76 (1.342.31)b 0.92 (0.631.35)
Prenatal / 1.14 (0.512.52) 1.16 (0.751.78) 0.49 (0.300.81)b 0.42 (0.230.78)
Preoperative / 3.22 (1.506.89) 1.21 (0.722.04) 1.14 (0.562.31)b 0.85 (0.352.04)
Other / 0.92 (0.551.54) 1.13 (0.861.49) 1.54 (1.112.14)b 1.03 (0.651.63)
CD4 at first visit
CD4 ]350 / / 1 1 1
CD4 B350 / / 1.16 (0.891.51) 8.02 (5.8011.11) 1.16 (0.781.70)
Note: Rem: pB0.05, statistically significant variables presented in italic.
aAdjusted for sex, age at diagnosis, nationality and ay of transmission; badditionally adjusted for CD4 value at first visit.
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